NCT03578302 is a clinical trial of BI Anterior Segment Mode in Normal Eyes, sponsored by Heidelberg Engineering GmbH.

Who is sponsoring NCT03578302?

NCT03578302 is sponsored by Heidelberg Engineering GmbH.

What drugs are being tested in NCT03578302?

Interventions in NCT03578302: BI Anterior Segment Mode, BI Anterior Segment and IOL Biometry Mode.

What condition does NCT03578302 study?

NCT03578302 studies Normal Eyes, Eye Abnormalities.

Is NCT03578302 still recruiting?

NCT03578302 is currently completed. Last updated 12 June 2025.

Last reviewed 2025-06-12 · How we verify

NCT03578302

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Heidelberg Engineering BI US Evaluation Study

Completed Last updated 12 June 2025

What this trial tests

trial testing BI Anterior Segment Mode in Normal Eyes in 39 participants. Completed in 3 December 2018.

Timeline

22 May 2018

Primary endpoint
3 December 2018

3 December 2018

Quick facts

Lead sponsor	Heidelberg Engineering GmbH
Status	Completed
Study type	OBSERVATIONAL
Enrollment	39
Start date	22 May 2018
Primary completion	3 December 2018
Estimated completion	3 December 2018
Sites	1 location across United States

Drugs / interventions tested

BI Anterior Segment Mode
BI Anterior Segment and IOL Biometry Mode

Conditions studied

Normal Eyes — all drugs for Normal Eyes →
Eye Abnormalities — all drugs for Eye Abnormalities →

Sponsor

Heidelberg Engineering GmbH

Who can join

18 and older, any sex, with Normal Eyes or Eye Abnormalities. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of defined parameters measured in pathological and non-pathological eyes with the Heidelberg BI

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Normal Eyes

Currently open trials in the same condition.

NCT05844852 — P200TE US Reference Database Study · NA · active not recruiting

Other Heidelberg Engineering GmbH trials

Trials by the same sponsor.

NCT07338461 — High Resolution Imaging OCT Study · NA · not yet recruiting
NCT06397976 — The Heidelberg Engineering ANTERION Software Comparison Precision and Agreement Study · terminated
NCT05051813 — The Heidelberg Engineering ANTERION Corneal Epithelium Thickness Precision and Agreement Study · completed
NCT04961398 — Evaluation of Heidelberg Engineering SPECTRALIS OCT Signal to Noise Ratio Effect on Parameter Measurements · completed
NCT04661124 — Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03578302 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Heidelberg Engineering GmbH
Last refreshed: 12 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03578302.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing